open access

Vol 26, No 6 (2019)
Original articles — Clinical cardiology
Published online: 2019-01-30
Get Citation

Postoperative high-sensitivity troponin T as a predictor of sudden cardiac arrest in patients undergoing cardiac surgery

Piotr Duchnowski, Tomasz Hryniewiecki, Mariusz Kuśmierczyk, Piotr Szymański
DOI: 10.5603/CJ.a2019.0005
·
Pubmed: 30701514
·
Cardiol J 2019;26(6):777-781.

open access

Vol 26, No 6 (2019)
Original articles — Clinical cardiology
Published online: 2019-01-30

Abstract

Background: The usefulness of high-sensitivity troponin T (hs-TnT) as a predictor of sudden cardiac
arrest (SCA) in patients undergoing valve surgery is currently unknown.
Methods: A prospective study was conducted on a group of 815 consecutive patients with significant
valvular heart disease that underwent elective valve surgery. The primary end-point was postoperative SCA.
Results: The postoperative SCA occurred in 26 patients. At multivariate analysis of hs-TnT measured
immediately after surgery (hs-TnT I) and age remained independent predictors of the primary end-point.
Conclusions: Elevated postoperative hs-TnT was associated with a higher risk of postoperative SCA.

Abstract

Background: The usefulness of high-sensitivity troponin T (hs-TnT) as a predictor of sudden cardiac
arrest (SCA) in patients undergoing valve surgery is currently unknown.
Methods: A prospective study was conducted on a group of 815 consecutive patients with significant
valvular heart disease that underwent elective valve surgery. The primary end-point was postoperative SCA.
Results: The postoperative SCA occurred in 26 patients. At multivariate analysis of hs-TnT measured
immediately after surgery (hs-TnT I) and age remained independent predictors of the primary end-point.
Conclusions: Elevated postoperative hs-TnT was associated with a higher risk of postoperative SCA.

Get Citation

Keywords

sudden cardiac arrest, high-sensitivity troponin T, valve surgery

About this article
Title

Postoperative high-sensitivity troponin T as a predictor of sudden cardiac arrest in patients undergoing cardiac surgery

Journal

Cardiology Journal

Issue

Vol 26, No 6 (2019)

Pages

777-781

Published online

2019-01-30

DOI

10.5603/CJ.a2019.0005

Pubmed

30701514

Bibliographic record

Cardiol J 2019;26(6):777-781.

Keywords

sudden cardiac arrest
high-sensitivity troponin T
valve surgery

Authors

Piotr Duchnowski
Tomasz Hryniewiecki
Mariusz Kuśmierczyk
Piotr Szymański

References (27)
  1. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. ESC Scientific Document Group . 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015; 36(41): 2793–2867.
  2. Eckart RE, Shry EA, Burke AP, et al. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol. 2011; 58(12): 1254–1261.
  3. Van Camp SP, Bloor CM, Mueller FO, et al. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc. 1995; 27(5): 641–647.
  4. Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol. 1991; 68(13): 1388–1392.
  5. Basso C, Carturan E, Pilichou K, et al. Sudden cardiac death with normal heart: molecular autopsy. Cardiovasc Pathol. 2010; 19(6): 321–325.
  6. Arking DE, Junttila MJ, Goyette P, et al. Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet. 2011; 7(6): e1002158.
  7. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346(12): 877–883.
  8. Gualandro DM, Puelacher C, Mueller C. High-sensitivity cardiac troponin in acute conditions. Curr Opin Crit Care. 2014; 20(5): 472–477.
  9. Parissis JT, Papadakis J, Kadoglou NPE, et al. Prognostic value of high sensitivity troponin T in patients with acutely decompensated heart failure and non-detectable conventional troponin T levels. Int J Cardiol. 2013; 168(4): 3609–3612.
  10. Guo R, Li Y, Wen J, et al. Elevated plasma level of pentraxin-3 predicts in-hospital and 30-day clinical outcomes in patients with non-ST-segment elevation myocardial infarction who have undergone percutaneous coronary intervention. Cardiology. 2014; 129(3): 178–188.
  11. Duchnowski P, Hryniewiecki T, Zatorska K, et al. High‑sensitivity troponin T as a prognostic marker in patients undergoing aortic valve replacement. Pol Arch Intern Med. 2017; 127(9): 628–630.
  12. Petäjä L, Røsjø H, Mildh L, et al. Predictive value of high-sensitivity troponin T in addition to EuroSCORE II in cardiac surgery. Interact Cardiovasc Thorac Surg. 2016; 23(1): 133–141.
  13. Duchnowski P, Hryniewiecki T, Kuśmierczyk M, et al. The usefulness of selected biomarkers in aortic regurgitation. Cardiol J. 2018 [Epub ahead of print].
  14. Reichlin T, Schindler C, Drexler B, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med. 2012; 172(16): 1211–1218.
  15. European patent 394816 and US patent 6376206 by Roche Diagnostic GmbH. Specific antibodies to Troponin T, their production and use in a reagent for the determination of myocardial necrosis.
  16. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem. 2012; 58(11): 1574–1581.
  17. Lepojärvi ES, Huikuri HV, Piira OP, et al. Biomarkers as predictors of sudden cardiac death in coronary artery disease patients with preserved left ventricular function (ARTEMIS study). PLoS One. 2018; 13(9): e0203363.
  18. Beausire T, Faouzi M, Palmiere C, et al. High-sensitive cardiac troponin hs-TnT levels in sudden deaths related to atherosclerotic coronary artery disease. Forensic Sci Int. 2018; 289: 238–243.
  19. Sharma A, Hijazi Z, Andersson U, et al. Use of biomarkers to predict specific causes of death in patients with atrial fibrillation. Insights from the ARISTOTLE Trial. Circulation. 2018; 138(16): 1666–1676.
  20. Nakamura H, Niwano S, Fukaya H, et al. Cardiac troponin T as a predictor of cardiac death in patients with left ventricular dysfunction. J Arrhythm. 2017; 33(5): 463–468.
  21. Carvajal-Zarrabal O, Hayward-Jones PM, Nolasco-Hipolito C, et al. Use of cardiac injury markers in the postmortem diagnosis of sudden cardiac death. J Forensic Sci. 2017; 62(5): 1332–1335.
  22. Rahimi R, Dahili ND, Anuar Zainun K, et al. Post mortem troponin T analysis in sudden death: Is it useful? Malays J Pathol. 2018; 40(2): 143–148.
  23. Lindman BR, Breyley JG, Schilling JD, et al. Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement. Heart. 2015; 101(17): 1382–1388.
  24. Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003; 107(7): 984–991.
  25. Weidemann F, Herrmann S, Störk S, et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation. 2009; 120(7): 577–584.
  26. Abramov D, Abu-Tailakh M, Frieger M, et al. Plasma troponin levels after cardiac surgery vs after myocardial infarction. Asian Cardiovasc Thorac Ann. 2006; 14(6): 530–535.
  27. Opfermann UT, Peivandi AA, Dahm M, et al. Postoperative patterns and kinetics of cTnI, cTnT, CK-MB-activity and CK-activity after elective aortic valve replacement. Swiss Med Wkly. 2001; 131(37-38): 550–555.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl